BTIG Research Upgrades Endologix To Buy, Shares Gain By: Benzinga via Benzinga August 25, 2014 at 08:41 AM EDT Analysts at BTIG Research upgraded Endologix (NASDAQ: ELGX) from Neutral to Buy. The target price for Endologix is set to $17. ... Read More >> Related Stocks: Endologix Inc